Fertility and Sterility
Volume 92, Issue 1 , Pages 320-327 , July 2009

Glycosaminoglycan and transforming growth factor β1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy

  • Pierina De Muro, M.D.

      Affiliations

    • Department of Physiological, Biochemical and Cellular Sciences, University of Sassari, Sassari, Italy
    • ,
  • Giampiero Capobianco, M.D., Ph.D.

      Affiliations

    • Department of Pharmacology, Gynecology and Obstetrics University of Sassari, Sassari, Italy
    • ,
  • Marilena Formato, M.D.

      Affiliations

    • Department of Physiological, Biochemical and Cellular Sciences, University of Sassari, Sassari, Italy
    • ,
  • Antonio Junior Lepedda, M.D.

      Affiliations

    • Department of Physiological, Biochemical and Cellular Sciences, University of Sassari, Sassari, Italy
    • ,
  • Gian Mario Cherchi, M.D.

      Affiliations

    • Department of Physiological, Biochemical and Cellular Sciences, University of Sassari, Sassari, Italy
    • ,
  • Laila Gordini, M.D.

      Affiliations

    • Department of Pharmacology, Gynecology and Obstetrics University of Sassari, Sassari, Italy
    • ,
  • Salvatore Dessole, M.D.

      Affiliations

    • Department of Pharmacology, Gynecology and Obstetrics University of Sassari, Sassari, Italy
    • Corresponding Author InformationReprint requests: Salvatore Dessole, M.D., Department of Pharmacology, Gynecology and Obstetrics, University of Sassari, Viale San Pietro 12, Sassari 07100, Italy (FAX: 39-079-228265).

Received 2 February 2008 ,Revised 2 May 2008 ,Accepted 19 May 2008.

References 

  1. Götte M. Syndecans in inflammation. FASEB J. 2003;17:575–591
  2. Tkachenko E, Rhodes JM, Simons M. Syndecans: new kids on the signaling block. Circ Res. 2005;96:488–500
  3. Trowbridge JM, Gallo RL. Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology. 2002;12:117–125
  4. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242:27–33
  5. Imanari T, Shinbo A, Ochiai H, Ikei T, Koshiishi I, Toyoda H. Study on proteoglycans having low-sulfated chondroitin 4 sulfate in human urine and serum. J Pharmacobiodyn. 1992;15:231–237
  6. Faarvang HJ. Urinary trypsin inhibitor in man (“Mingin”). Scand J Clin Lab Invest. 1965;17:1–78
  7. Nakane M, Iwama H. Intra-alveolar urinary trypsin inhibitor cannot inhibit polymorphonuclear elastase activity in the lung in postsurgical patients with acute respiratory distress syndrome. Surg Today. 1999;29:1030–1033
  8. Shikimi T, Suzuki S, Wessel T, Joh TH, Hattori K, Takaori S. Human urinary trypsin inhibitor (urinastatin)-like substance in mouse liver. Life Sci. 1992;50:1399–1406
  9. Hochstrasser K, Schonberger OL, Lempart K, Metzger M. Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor. VI. Detection of a complex between immunoglobulin g and the inhibitory active part of the inter-alpha-trypsin inhibitor. Hoppe Seylers Z Physiol Chem. 1981;362:1363–1367
  10. Camaioni A, Hascall VC, Yanagishita M, Salustri A. Effects of exogenous hyaluronic acid and serum on matrix organization and stability in the mouse cumulus cell-oocyte complex. J Biol Chem. 1993;268:20473–20481
  11. Kanayama N, el Maradny E, Halim A, Liping S, Maehara K, Kajiwara Y, et al. Urinary trypsin inhibitor prevents uterine muscle contraction by inhibition of Ca++ influx. Am J Obstet Gynecol. 1995;173:192–199
  12. Mulheron GW, Bossert NL, Lapp JA, Walmer DK, Schomberg DW. Human granulosa-luteal and cumulus cells express transforming growth factors-beta type 1 and type 2 mRNA. J Clin Endocrinol Metab. 1992;74:458–460
  13. Polli V, Bulletti C, Galassi A, Borini A, Ciotti PM, Seracchioli R, et al. Transforming growth factor-beta 1 in the human endometrium. Gynecol Endocrinol. 1996;10:297–302
  14. De Muro P, Faedda R, Formato M, Re F, Satta A, Cherchi GM, et al. Urinary glycosaminoglycans in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2001;19:125–130
  15. Cherchi GM, Formato M, Demuro P, Masserini M, Varani I, De Luca G. Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes. Biochim Biophys Acta. 1994;1212:345–352
  16. al-Hakim A, Linhardt RJ. Capillary electrophoresis for the analysis of chondroitin sulfate- and dermatan sulfate-derived disaccharides. Anal Biochem. 1991;195:68–73
  17. De Muro P, Faedda R, Satta AE, Masala A, Cigni A, Falconi D, et al. Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity. Scand J Urol Nephrol. 2007;41:230–236
  18. Enghild JJ, Thogersen IB, Cheng F, Fransson LA, Roepstorff P, Rahbek-Nielsen H. Organization of the inter-alpha-inhibitor heavy chains on the chondroitin sulfate originating from Ser(10) of bikunin: posttranslational modification of IalphaI-derived bikunin. Biochemistry. 1999;38:11804–11813
  19. Kanayama N, el Maradny E, Halim A, Maehara K, Kajiwara Y, Terao T. Urinary trypsin inhibitor suppresses premature cervical ripening. Eur J Obstet Gynecol Reprod Biol. 1995;60:181–186
  20. El Maradny E, Kanayama N, Halim A, Maehara K, Kobayashi T, Terao T. Effects of urinary trypsin inhibitor on myometrial contraction in term and preterm deliveries. Gynecol Obstet Invest. 1996;41:96–102
  21. Weilke C, Brinkmann T, Kleesiek K. Determination of xylosyltransferase activity in serum with recombinant human bikunin as acceptor. Clin Chem. 1997;43:45–51
  22. Kobayashi H, Suzuki K, Sugino D, Terao T. Urinary trypsin inhibitor levels in amniotic fluid of normal human pregnancy: decreased levels observed at parturition. Am J Obstet Gynecol. 1999;180:141–147
  23. Fried G, Wramsby H, Tally M. Transforming growth factor-beta1, insulin-like growth factors, and insulin-like growth factor binding proteins in ovarian follicular fluid are differentially regulated by the type of ovarian hyperstimulation used for in vitro fertilization. Fertil Steril. 1998;70:129–134
  24. Ogasawara MS, Aoki K, Aoyama T, Katano K, Iinuma Y, Ozaki Y, et al. Elevation of transforming growth factor-beta1 is associated with recurrent miscarriage. J Clin Immunol. 2000;20:453–457
  25. Dungy LJ, Siddiqi TA, Khan S. Transforming growth factor-beta 1 expression during placental development. Am J Obstet Gynecol. 1991;165:853–857
  26. Hatthachote P, Gillespie JI. Complex interactions between sex steroids and cytokines in the human pregnant myometrium: evidence for an autocrine signaling system at term. Endocrinology. 1999;140:2533–2540

 P.D.M. has nothing to disclose. G.C. has nothing to disclose. M.F. has nothing to disclose. A.J.L. has nothing to disclose. G.M.C. has nothing to disclose. L.G. has nothing to disclose. S.D. has nothing to disclose.

PII: S0015-0282(08)01182-5

doi: 10.1016/j.fertnstert.2008.05.066

Fertility and Sterility
Volume 92, Issue 1 , Pages 320-327 , July 2009

Article Tools

* Image Usage & Resolution